We are part of a globally networked system of innovation. All the top 10 global pharmaceutical companies operate in Ireland – the likes of GSK, Pfizer, AbbVie, Novartis, MSD and many more. They are part of Ireland’s enterprise ecosystem, with a huge impact in societal, economic and human health terms. 

Over the past 10 years, the originator pharmaceutical industry has invested close to €10 billion in manufacturing and research sites around the country. That represents close to the biggest wave of investment in new biotechnology facilities anywhere in the world. Between 2003 and 2018, the number of biotechnology manufacturing sites jumped from two to twenty.

These numbers are impressive – but they are no cause for complacency. Ireland must continue to pursue excellence in manufacturing and research, and adapt public policy to the promise of innovation in new medicines. If we do that, our industry will remain a reliable source of high-quality, well-paid jobs well into the future.

Click here to read the full campaign.